MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Monday, June 20, 2016

12:30pm-2:00pm
How do patients experience deep brain stimulation surgery: A prospective patient satisfaction survey

A. Fazl, M. Gillego, A. Mogliner, M.H. Pourfar (New York, NY, USA)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
How long is the wait to see a Parkinson’s disease specialist in the United States?

S.G. Reich, K. Holmes, J. Martello, K. Maki (Baltimore, MD, USA)

Quality of life/caregiver burden in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
How many and which kind of Parkinson’s disease patients need deep brain stimulation surgery? An evaluation based on clinical observation of patients with disease history of 15th year or more

H. Shibayama, T. Fukumoto, M. Tomura, K. Tokumoto, H. Yano, K. Tajima, F. Mitobe, F. Katada, S. Sato, T. Fukutake (Kamogawa City, Chiba, Japan)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Hyposmia as a predictor of non-motor symptom in patients with de novo Parkinson’s disease

M. Sanoeva, N. Mansurova, A. Prokhorova (Bukhara, Uzbekistan)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Hypothalamic alpha-synuclein pathology and its relation to non-motor symptoms and disease progression in Parkinson’s disease

E. De Pablo-Fernandez, R. Courtney, J.L. Holton, T.W. Warner (London, United Kingdom)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson’s disease

D.P. Breen, C. Nombela, R. Vuono, P.S. Jones, K. Fisher, D.J. Burn, D.J. Brooks, A.B. Reddy, J.B. Rowe, R.A. Barker (Cambridge, United Kingdom)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Identification of barriers preventing disclosure of non-motor symptoms in Parkinson’s patients to healthcare providers

C.S. Hurt, L. Rixon, K.R. Chaudhuri, R. Moss-Morris, M. Samuel, R.G. Brown (London, United Kingdom)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Identification of premotor Parkinson’s disease

K.C. Hughes, X. Gao, M.A. Schwarzschild, A. Ascherio (Boston, MA, USA)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Identification of unique metabolite signatures in post-mortem DBS human tissue using LC-HRMS

V. Vedam-Mai, S. Sternberg, M. Williams, T. Garrett, M.S. Okun (Gainesville, FL, USA)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review

C.M.K.E. de Cuba, A. Albanese, A. Antonini, G. Cossu, G. Deuschl, R. Eleopra, A. Galati, C.F.E. Hoffman, K. Knudsen, A. Landi, M.M.R. Lanotte, A. Marcante, A. Mosch, M. Pilleri, M.M. Reich, V. Ricchi, S. Rinaldo, L.M. Romito, F. Saba, H.E. Sacristan, P.R. Schuurman, A. Trezza, P. van den Munckhof, J. Volkmann, M. Zibetti, M.F. Contarino (Amsterdam, Netherlands)

Surgical Therapy
  • «Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 53
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley